About Dimitris Linardatos

This author has not yet filled in any details.
So far Dimitris Linardatos has created 208 blog entries.

IASIS PHARMA PARTICIPATION IN THE 26TH PANHELLENIC WEBINAR FOR H. PYLORI AND OTHER DIGESTIVE INFECTIONS

03/05/2021|All articles, Press Room|

Hellenic Gastroenterological Society Amphitheater, Athens, 16-18/04/2021 IASIS PHARMA, with a high sense of responsibility and adapted to the peculiarities of the COVID-19 period, successfully participated in the 26th Greek Webinar for Helicobacter pylori & Other Digestive Infections. The conference was organized by the Hellenic Gastroenterological Society and the Hellenic Society for Infections and it was [...]

COVED® NEW PRODUCT LAUNCH

23/04/2021|All articles, Product launches|

IASIS PHARMA has successfully launched COVED® to the Greek market. COVED® (Bisphosphonates, combinations) is a fixed dose combination of two active ingredients: Alendronic acid (as alendronate sodium trihydrate) (70mg) & Cholecalciferol (Vitamin D3) (5.600 I.U). COVED® 70 mg / 5,600 IU is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D [...]

GLUCOPLUS®1.000mg NEW 60 F.C. TABS PACKAGE

05/04/2021|All articles, Product launches|

IASIS PHARMA is pleased to announce the launch of the new 60 f.c. tabs packaging for GLUCOPLUS® 1.000mg (Metformin hydrochloride). Both GLUCOFREE® & GLUCOPLUS® (active ingredient: metformin hydrochloride) belong to the broader category of Oral Hypoglycemic Agents (OHAs) for the treatment of Type 2 Diabetes Mellitus (T2D) as first-line therapy. GLUCOFREE® is available in 850mg metformin hydrochloride, [...]

IASIS PHARMA: ENTERING 2021 WITH HEALTH, PREVENTION AND SAFETY

14/01/2021|All articles, Company news|

Winter vacation period has just ended, also affected by covid-19 pandemic. Nevertheless, IASIS PHARMA stayed focused on its corporate responsibility, in order all employees return to their jobs safely. More specifically, before their return, all IASIS PHARMA employees were re-tested for covid-19. The tests were carried out by a well-established private clinic at IASIS PHARMA [...]

IASIS PHARMA PARTICIPATION IN THE 40th PANHELLENIC GASTROENTEROLOGICAL WEBINAR

10/12/2020|All articles, Press Room|

Webinar date:  3 - 6 /12/2020 COVID-19 pandemic has not only caused an unexpected global crisis, but also serious social and economic disruption. Consequently it has led worldwide, as well as in our country, to the postponement or  cancellation of scientific events and seminars. However, some of them are held in the form of webinars. [...]

IASIS PHARMA PARTICIPATION IN THE 20th PANHELLENIC HYPERTENSION CONFERENCE – WEBINAR EVENT

30/11/2020|All articles, Press Room|

19-21/11/2020 Despite CoViD19 pandemic predicaments, IASIS PHARMA successfully participated in the 20th Panhellenic Hypertension Conference Webinar, organized by the Hellenic Hypertension Society (HHS), which took place on November 19-21, 2020. IASIS PHARMA supported the HHS effort, as there is an increasing number of adults in Greece having high blood pressure. At the same time, there [...]

IASIS PHARMA PARTICIPATION IN THE WEBINAR “25th HELLENIC CONFERENCE ON HELICOBACTER PYLORI AND OTHER DIGESTIVE INFECTIONS”

13/11/2020|All articles, Press Room|

Hellenic Gastroenterological Society Amphitheater, Athens, 6 - 7/11/2020 Despite Coronavirus pandemic predicament, IASIS PHARMA, with high sense of responsibility, successfully participated as a Gold Sponsor in the “25th Hellenic Conference of the Helicobacter Pylori & other Digestive Infections”. The conference was organized by the “Hellenic Society of Gastroenterology and the “Hellenic Society for Infectious Diseases” [...]

SENSIBIO 30® g. NEW PACKAGE

09/11/2020|All articles, Product launches|

IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Sensibio® in 30 g. new package. Sensibio® 30 g. new package was launched to the market in order to complete Sensibio® 15 g., the well-established fixed combination of Fusidic acid (antibiotic) and [...]

FLUSTERIX® 30 g. NEW PACKAGE

09/11/2020|All articles, Product launches|

IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Flusterix® in 30 g. new package. Flusterix® 30 g. was launched in order to complete the, well-established to the pharmaceutical market, Flusterix® 15 g. package. Flusterix® has Fusidic acid as its active ingredient, [...]

IASIS PHARMA PARTICIPATION IN THE 2020 ONLINE HELLENIC EDUCATIONAL WORKSHOP OF EPEGE

26/10/2020|All articles, Press Room|

COVID-19 pandemic has caused an unprecedented, global health crisis. Moreover, one of the other numerous problems that COVID-19 has caused, is the lack of scientific events with physical appearance. Despite that, many scientific events are carried out online. One of these events was the Online Educational Workshop of the Professional Association of Greek Gastroenterologists (EP.E.G.E), [...]

Load More Posts